Exane Derivatives Bristol Myers Squibb CO Transaction History

Exane Derivatives

$157 Million
Q2 2022

A detailed history of Exane Derivatives transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Exane Derivatives holds 17,094 shares of BMY stock, worth $832,477. This represents 0.84% of its overall portfolio holdings.

Number of Shares

17,094

Previous 10,833 57.8%

Holding current value

$832,477

Previous $791,000 66.37%

% of portfolio

0.84%

Previous 0.24%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	BUY	$72.62 - $79.98 $454,673 - $500,754	6,261 Added 57.8%	17,094 $1.32 Million
Q1 2022 Apr 22, 2022	SELL	$61.48 - $73.72 $697,859 - $836,795	-11,351 Reduced 51.17%	10,833 $791,000
Q4 2021 Jan 28, 2022	BUY	$53.63 - $62.52 $223,905 - $261,021	4,175 Added 23.18%	22,184 $1.38 Million
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $27,809 - $32,575	470 Added 2.68%	18,009 $1.07 Million
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $72,125 - $78,544	-1,165 Reduced 6.23%	17,539 $1.17 Million
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $18,217 - $20,489	-307 Reduced 1.61%	18,704 $1.18 Million
Q4 2020 Jan 27, 2021	SELL	$57.74 - $65.43 $1.01 Million - $1.15 Million	-17,572 Reduced 48.03%	19,011 $1.18 Million
Q3 2020 Oct 06, 2020	BUY	$57.43 - $63.64 $1.03 Million - $1.15 Million	18,001 Added 96.87%	36,583 $2.21 Million
Q2 2020 Jul 10, 2020	SELL	$54.82 - $64.09 $162,705 - $190,219	-2,968 Reduced 13.77%	18,582 $1.09 Million
Q1 2020 Apr 17, 2020	SELL	$46.4 - $67.43 $38,326 - $55,697	-826 Reduced 3.69%	21,550 $1.2 Million
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $319,126 - $416,272	6,485 Added 40.81%	22,376 $1.44 Million
Q3 2019 Oct 15, 2019	BUY	$42.77 - $50.71 $436,254 - $517,242	10,200 Added 179.23%	15,891 $805,000
Q2 2019 Jul 12, 2019	SELL	$44.62 - $49.34 $376,101 - $415,886	-8,429 Reduced 59.7%	5,691 $0
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $589,312 - $702,681	-13,061 Reduced 48.05%	14,120 $0
Q4 2018 Jan 31, 2019	BUY	$48.76 - $63.23 $1.09 Million - $1.42 Million	22,454 Added 475.02%	27,181 $1.41 Million
Q3 2018 Oct 24, 2018	SELL	$55.19 - $62.25 $359,673 - $405,683	-6,517 Reduced 57.96%	4,727 $0
Q2 2018 Jul 19, 2018	BUY	$50.53 - $62.98 $319,349 - $398,033	6,320 Added 128.35%	11,244 $0
Q1 2018 Apr 30, 2018	BUY	$59.92 - $68.98 $15,938 - $18,348	266 Added 5.71%	4,924 $0
Q4 2017 Jan 29, 2018	BUY	$59.94 - $65.35 $63,236 - $68,944	1,055 Added 29.28%	4,658 $0
Q3 2017 Oct 18, 2017	BUY	$55.23 - $63.74 $198,993 - $229,655	3,603	3,603 $0

Others Institutions Holding BMY

# of Institutions

2,399

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account

Exane Derivatives Bristol Myers Squibb CO Transaction History